Impact of maternal angiotensinogen M235T polymorphism and angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure, protein excretion and fetal outcome in pregnancy

Journal of Hypertension

Volumn 25, Issue 6, 2007, Pages 1255-1261

  Pfab, Thiemo ^a,b   Stirnberg, Bulza ^b   Sohn, Andreas ^b   Krause, Katrin ^b   Slowinski, Torsten ^a   Godes, Michael ^b   Guthmann, Florian ^a   Wauer, Roland ^a   Halle, Horst ^a   Hocher, Berthold ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Blood pressure; Congenital malformations; Genetic polymorphism; Gestational hypertension

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR MALFORMATION; CAUCASIAN; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; EDEMA; FEMALE; FETUS GROWTH; FETUS OUTCOME; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HOMOZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; URINARY EXCRETION;

EID: 34250348267     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3280d35834     Document Type: Article

References (42)

1. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105:94-113.
2. Nielsen AH, Schauser KH, Poulsen K. Current topic: the uteroplacental renin-angiotensin system. Placenta 2000; 21:468-477.
3. Peters J. Molecular basis of human hypertension: the role of angiotensin. Baillieres Clin Endocrinol Metab 1995; 9:657-678.
4. August P, Lenz T, Ales KL, Druzin ML, Edersheim TG, Hutson JM, et al. Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol 1990; 163:1612- 1621.
5. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PC. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973; 52:2682-2689.
6. Morgan T, Craven C, Lalouel JM, Ward K. Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua. Am J Obstet Gynecol 1999; 180:95-102.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86:1343-1346.
8. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51:197-205.
9. Mello G, Parretti E, Gensini F, Sticchi E, Mecacci F, Scarselli G, et al. Maternal-fetal flow, negative events, and preeclampsia: role of ACE I/D polymorphism. Hypertension 2003; 41:932-937.
10. Kobashi G, Hata A, Shido K, Kato EH, Yamada H, Fujimoto S, et al. Association of a variant of the angiotensinogen gene with pure type of hypertension in pregnancy in the Japanese: implication of a racial difference and significance of an age factor. Am J Med Genet 1999; 86:232-236.
11. Roberts CB, Rom L, Moodley J, Pegoraro RJ. Hypertension-related gene polymorphisms in pre-eclampsia, eclampsia and gestational hypertension in Black South African women. J Hypertens 2004; 22:945-948.
12. Kobashi G, Hata A, Ohta K, Yamada H, Kato EH, Minakami H, et al. A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J Hum Genet 2004; 49:182-186.
13. Guo G, Wilton AN, Fu Y, Qiu H, Brennecke SP, Cooper DW. Angiotensinogen gene variation in a population case-control study of preeclampsia/eclampsia in Australians and Chinese. Electrophoresis 1997; 18:1646-1649.
14. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, et al. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet 1993; 4:59-61.
15. Kim YJ, Park MH, Park HS, Lee KS, Ha EH, Pang MG. Associations of polymorphisms of the angiotensinogen M235 polymorphism and angiotensin- converting-enzyme intron 16 insertion/deletion polymorphism with preeclampsia in Korean women. Eur J Obstet Gynecol Reprod Biol 2004; 116:48-53.
16. Kobashi G, Shido K, Hata A, Yamada H, Kato EH, Kanamori M, et al. Multivariate analysis of genetic and acquired factors; T235 variant of the angiotensinogen gene is a potent independent risk factor for preeclampsia. Semin Thromb Hemost 2001; 27:143-147.
17. Choi H, Kang JY, Yoon HS, Han SS, Whang CS, Moon IG, et al. Association of angiotensin-converting enzyme and angiotensinogen gene polymorphisms with preeclampsia. J Korean Med Sci 2004; 19:253-257.
18. Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE, Siamopoulos KC, Georgiou I. Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 110:8-11.
19. Bashford MT, Hefler LA, Vertrees TW, Roa BB, Gregg AR. Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol 2001; 184:1345-1350.
20. Procopciuc L, Jebeleanu G, Surcel I, Puscas M. Angiotensinogen gene M235T variant and pre-eclampsia in Romanian pregnant women. J Cell Mol Med 2002; 6:383-388.
21. Morgan L, Crawshaw S, Baker PN, Broughton PF, Kalsheker N. Maternal and fetal angiotensinogen gene allele sharing in pre-eclampsia. Br J Obstet Gynaecol 1999; 106:244-251.
22. Suzuki Y, Tanemura M, Suzuki Y, Murakami I, Suzumori K. Is angiotensinogen gene polymorphism associated with hypertension in pregnancy? Hypertens Pregnancy 1999; 18:261-271.
23. Gurdol F, Isbilen E, Yilmaz H, Isbir T, Dirican A. The association between preeclampsia and angiotensin-converting enzyme insertion/deletion polymorphism. Clin Chim Acta 2004; 341:127-131.
24. Heiskanen JT, Pirskanen MM, Hiltunen MJ, Mannermaa AJ, Punnonen KR, Heinonen ST. Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia. Am J Obstet Gynecol 2001; 185:600-603.
25. Kobashi G, Hata A, Shido K, Ohta K, Yamada H, Kato EH, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and preeclampsia in Japanese patients. Semin Thromb Hemost 2005; 31:346-350.
26. Kaur R, Jain V, Khuller M, Gupta I, Sherawat BS. Association of angiotensin-converting enzyme gene polymorphism with pregnancy-induced hypertension. Acta Obstet Gynecol Scand 2005; 84:929-933.
27. Morgan L, Foster F, Hayman R, Crawshaw S, Baker PN, Broughton PF, et al. Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies. J Hypertens 1999; 17:765-768.
28. Galao AO, de Souza LH, da Costa BE, Scheibe RM, Poli de Figueiredo CE. Angiotensin-converting enzyme gene polymorphism in preeclampsia and normal pregnancy. Am J Obstet Gynecol 2004; 191:821-824.
29. Pfab T, Chen YP, Slowinski T, Richter CM, Godes M, Arck PC, et al. Impact of genes related to immune tolerance and inflammation (tumour necrosis factor-alpha, interleukin-6) on blood pressure, protein excretion and oedema in pregnancy. J Hypertens 2005; 23:2187-2191.
30. Hocher B, Slowinski T, Bauer C, Halle H. The advanced fetal programming hypothesis. Nephrol Dial Transplant 2001; 16:1298-1299.
31. Hocher B, Slowinski T, Stolze T, Pleschka A, Neumayer HH, Halle H. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 2000; 355:1241-1242.
32. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 2002; 287:195-202.
33. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
34. Hocher B, Slowinski T, Hauser I, Vetter B, Fritsche L, Bachert D, et al. Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients. Thromb Haemost 2002; 87:194-198.
35. Filler G, Yang F, Martin A, Stolpe J, Neumayer HH, Hocher B. Renin angiotensin system gene polymorphisms in pediatric renal transplant recipients. Pediatr Transplant 2001; 5:166-173.
36. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345:1600-1603.
37. Bloem LJ, Manatunga AK, Pratt JH. Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996; 27:62-66.
38. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001; 38:718-722.
39. Rotimi C, Cooper R, Ogunbiyi O, Morrison L, Ladipo M, Tewksbury D, et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. Circulation 1997; 95:2348-2350.
40. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
41. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354:2443-2451.
42. Quan A. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 2006; 82:23-28.